Analyst Ratings For Supernus Pharmaceuticals (NASDAQ:SUPN)
Today, Cantor Fitzgerald reiterated its Buy rating on Supernus Pharmaceuticals (NASDAQ:SUPN) with a price target of $49.00.
There are 2 hold ratings, 4 buy ratings on the stock.
The current consensus rating on Supernus Pharmaceuticals (NASDAQ:SUPN) is Buy (Score: 2.67) with a consensus target price of $48.17 per share, a potential 2.99% downside.
Some recent analyst ratings include
- 9/19/2017-Cantor Fitzgerald Reiterated Rating of Buy.
- 9/8/2017-Piper Jaffray Companies Reiterated Rating of Hold.
- 8/4/2017-Jefferies Group LLC Reiterated Rating of Buy.
- 8/3/2017-Cowen and Company Reiterated Rating of Outperform .
- 7/18/2017-Stifel Nicolaus Reiterated Rating of Buy.
- 7/14/2017-Janney Montgomery Scott initiated coverage with a Neutral rating.
- 7/18/2016-Northland Securities was Downgraded by analysts at Northland Securities from a “Outperform ” rating to a ” Market Perform” rating. They now have a $24.00 price target on the stock.
Recent Insider Trading Activity For Supernus Pharmaceuticals (NASDAQ:SUPN)
Supernus Pharmaceuticals (NASDAQ:SUPN) has insider ownership of 6.70% and institutional ownership of 95.38%.
- On 9/8/2017 Gregory S. Patrick, CFO, sold 50,000 with an average share price of $47.60 per share and the total transaction amounting to $2,380,000.00. View SEC Filing
- On 9/8/2017 Padmanabh P Bhatt, SVP, sold 5,000 with an average share price of $49.86 per share and the total transaction amounting to $249,300.00. View SEC Filing
- On 9/7/2017 Stefan K.F. Schwabe, Insider, sold 95,000 with an average share price of $46.59 per share and the total transaction amounting to $4,426,050.00. View SEC Filing
- On 8/16/2017 Padmanabh P Bhatt, VP, sold 3,709 with an average share price of $45.23 per share and the total transaction amounting to $167,758.07. View SEC Filing
- On 7/12/2017 Padmanabh P Bhatt, VP, sold 3,735 with an average share price of $44.90 per share and the total transaction amounting to $167,701.50. View SEC Filing
- On 6/23/2017 Padmanabh P Bhatt, VP, sold 2,556 with an average share price of $44.90 per share and the total transaction amounting to $114,764.40. View SEC Filing
- On 6/2/2017 Padmanabh P Bhatt, VP, sold 10,000 with an average share price of $39.86 per share and the total transaction amounting to $398,600.00. View SEC Filing
Recent Trading Activity for Supernus Pharmaceuticals (NASDAQ:SUPN)
Shares of Supernus Pharmaceuticals closed the previous trading session at with shares trading hands.